Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02049918 · ClinicalTrials.gov registry record
Residual Sample Collection for Respiratory Viral Panel
A clinical trial of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus, sponsored by GenMark Diagnostics.
- Completed
- Registry status
- 1,487
- Enrollment target
- 1
- Study location
NCT02049918 is a study of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus that has completed, run by GenMark Diagnostics. The registered enrollment target is 1,487 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02049918, a study of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus, has completed, sponsored by GenMark Diagnostics.
- COMPLETED
- Registry status
- 1,487 participants
- Enrollment target
- 1
- Study location
Study Summary
Collect de-identified, residual samples to support a clinical trial. Samples may be prospectively or retrospectively collected. Overall Study Objective Obtain clinical performance data to characterize clinical performance of the Respiratory Viral Panel on the GenMark Sample-to-Answer Platform.
Conditions Studied
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,487 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02049918
The ClinicalTrials.gov registry entry for NCT02049918 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,487 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GenMark Diagnostics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus appearing as the primary indexed condition, and to 0 interventions.
NCT02049918 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02049918 about?
NCT02049918 is a clinical study titled "Residual Sample Collection for Respiratory Viral Panel". Collect de-identified, residual samples to support a clinical trial. Samples may be prospectively or retrospectively collected. Overall Study Objective Obtain clinical performance data to characterize clinical performance of the Respiratory Viral Panel on the GenMark Sample-to-Answer Platform.
What is the current status of trial NCT02049918?
This trial is currently completed. The enrollment target is 1,487 participants. The study started on 2013-11. Estimated completion is 2015-11.
What conditions does trial NCT02049918 study?
This clinical trial studies the following conditions: Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus.
Who is sponsoring clinical trial NCT02049918?
This trial is sponsored by GenMark Diagnostics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02049918 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.